Novo Nordisk reported DKK64.01B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
Bausch Health Companies USD 2.08B 294M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Novo Nordisk DKK 83.22B 19.21B Mar/2026
Pacira USD 133.91M 7.27M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
Supernus Pharmaceuticals USD 160.06M 30.7M Jun/2026